- Vienna 2018
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
Session Title: Phakic IOL Implantation II
Session Date/Time: Wednesday 09/10/2013 | 08:00-10:30
Paper Time: 08:44
Venue: E104-105 (First Floor)
First Author: : T.Althomali SAUDI ARABIA
Co Author(s): :
Posterior chamber toric phakic intraocular lens implantation for the management of anisometropia with astigmatism and amblyopia
Taif university,Saudi Arabia
Six eyes of 6 amblyopic patients, aged 5 to 15 years underwent toric phakic IOL implantation for refractory anisometropic amblyopia. Preoperative and postoperative clinical evaluation included slit-lamp microscopy, visual acuity, anterior/posterior segment examination and cycloplegic refraction.
After a mean follow-up of ~23 months, mean SEq cycloplegic refraction improved from -10.21 ± 4.62 D (range -7.5 D to -19.5 D) preoperatively to -0.42 ± 0.39 (-0.625 to +0.125) D postoperatively. Preoperative CDVA ranged from 20/40 to 20/200 and postoperative from 20/20 to 20/60. Five of the 6 eyes gained >3 lines in CDVA with a maximum gain of 8 lines in one eye. One eye that showed an improvement of > 2 lines improved from 20/100 preoperatively to 20/60 postoperatively. No patients lost any line of visual acuity. No inflammatory reactions were observed and the toric pIOLs remained well centered with no rotation from the desired position.
In children with refractory amblyopia due to anisometropia and astigmatism, implantation of toric pIOL may be a viable alternative to the traditional medical treatment with glasses and contact lens. However, longer follow-up is needed to evaluate the long-term risks and benefits.
Please wait while information is loading.